Prevalence and Factors Associated With Atrial Fibrillation in Patients With Type 2 Diabetes

This case-control study was conducted at Burapha University Hospital. The 12-lead electrocardiography recordings of type 2 diabetes patients were reviewed by a cardiologist to confirm the presence of atrial fibrillation. The clinical parameters, including age, sex, body-mass index, underlying medical conditions, blood pressure, heart rate, type 2 diabetes duration, laboratory values, and medications were analyzed and compared between atrial fibrillation and non-atrial fibrillation patients.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Atrial Fibrillation Arrhythmias, Cardiac Cardiovascular Diseases Diabetes Mellitus Diabetes Mellitus, Type 2 Endocrine System Diseases Glucose Metabolism Disorders Heart Diseases Metabolic Diseases Nutritional and Metabolic Diseases Pathologic Processes Pathological Conditions, Signs and Symptoms Type 2 Diabetes

Sex eligibility

All sexes

Study type

Observational

Primary location

Burapha University Hospital

Mueang, Changwat Chon Buri, 20131, Thailand

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Outpatients with type 2 diabetes who visited the medical clinic between June 2022 and June 2023

Exclusion criteria

Patients with missing information on the urinary albumin value and electrocardiograms at the latest date

Treatment and study plan

Routine examinations

Other

Electrocardiography and clinical parameters examinations, including age, sex, body-mass index, underlying medical conditions, blood pressure, heart rate, type 2 diabetes duration, laboratory values, and medications

Primary outcomes

Prevalence of atrial fibrillation

Time frame: June 2022 and June 2023

Prevalence of atrial fibrillation in patients with type 2 diabetes
Factors associated with atrial fibrillation

Time frame: June 2022 and June 2023

Factors associated with atrial fibrillation in patients with type 2 diabetes, including age, hypertension, heart failure, thyroid disease, type 2 diabetes duration, body mass index, estimated glomerular filtration rate, glycated hemoglobin, presence of albuminuria, and use of diuretic medications

Sponsors and collaborators

Lead sponsor

Burapha University

Other

Registry information

Official study title

Prevalence and Factors Associated With Atrial Fibrillation in Patients With Type 2 Diabetes: A Case-Control Study

Important dates

Study start: 2022
Primary completion: 2023
Study completion: 2023
First posted: Dec 18, 2023
Registry last updated: Dec 18, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed